The conference “Understanding the Neurovascular Network to Prevent Dementia” will bring together leading international experts to address the role of vascular health in preventing cognitive decline and dementia
A new analysis of the DapaTAVI trial, published in the European Journal of Heart Failure, confirms that dapagliflozin improves outcomes after TAVI regardless of cardiac function.
The research, presented in a Hot Line session at the European Society of Cardiology Congress in Munich and published simultaneously in The New England Journal of Medicine, proposes a paradigm shift towards prevention based on early detection through vascular imaging
The aim of the Acércate Programme is to train the brightest young people from a very early age in order to build a pool of outstanding researchers in the field of cardiovascular research
